XIAP and head and neck squamous cell carcinoma: IAPs, including XIAP and cIAP1/2, have been shown to be frequently overexpressed in various cancers [34,38], including SCCHN [47], and increase the resistance of cancer cells to apoptosis and prevent cell death induced by anticancer treatments, such as chemotherapy and radiotherapy [31,32,48,49].